FORTE BIOSCIENCES, INC. Research and Development in Process
FORTE BIOSCIENCES, INC. (FBRX) reported Research and Development in Process of $32.10 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2022-03-31
- FORTE BIOSCIENCES, INC. research and development in process for the quarter ending 2021-03-31 was $32.10M.
- FORTE BIOSCIENCES, INC. research and development in process for the quarter ending 2020-12-31 was $0.00.
- FORTE BIOSCIENCES, INC. research and development in process for the quarter ending 2020-09-30 was $0.00.
- FORTE BIOSCIENCES, INC. research and development in process for the quarter ending 2020-06-30 was $32.06M.
- FORTE BIOSCIENCES, INC. research and development in process for fiscal 2020 was $32.06M.
| Period end | Research and Development in Process | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|---|
| 2021-03-31 | $32.10M 10-Q · filed 2021-05-10 | $32.10M derived: sum of 2 quarters · filed 2022-03-31 | $32.10M derived: sum of 3 quarters · filed 2022-03-31 | $64.16M derived: sum of 4 quarters · filed 2022-03-31 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $32.06M derived: sum of 3 quarters · filed 2022-03-31 | $32.06M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $32.06M derived: sum of 2 quarters · filed 2021-11-08 | $32.06M 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | $32.06M 10-Q · filed 2021-08-16 | $32.06M 10-Q · filed 2021-08-16 | |||
| 2020-06-15 | $32.10M 10-Q · filed 2021-11-08 |